We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
-17.55%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
–
AUM
$28.5M
AUM Growth
-$42.5M
Cap. Flow
-$44.1M
Cap. Flow %
-154.82%
Top 10 Hldgs %
79.95%
Holding
53
New
16
Increased
1
Reduced
7
Closed
16

Top Buys

Rank Stock Value
1
ZGYHU
Yunhong International Unit
ZGYHU
+$3.45M
2
BXRX
Baudax Bio, Inc. Common Stock
BXRX
+$2.92M
3
ENLV icon
Enlivex Ltd
ENLV
+$2.84M
4
DMK
DMK Pharmaceuticals Corporation Common Stock
DMK
+$2.06M
5
PHIO icon
Phio Pharmaceuticals
PHIO
+$2.05M

Top Sells

Rank Stock Value
1
ABEO icon
Abeona Therapeutics
ABEO
+$17.1M
2
AMRS
Amyris Inc.
AMRS
+$5.74M
3
REPL icon
Replimune Group
REPL
+$5.25M
4
MNKD icon
MannKind Corp
MNKD
+$4.78M
5
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
+$4.58M

Sector Composition

Rank Sector Weight
1 Healthcare 33.11%
2 Communication Services 2.79%
3 Technology 2.11%
4 Materials 1.01%
5 Consumer Staples 0.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZGYHU
1
DELISTED
Yunhong International Unit
ZGYHU
$3.33M 11.68%
+350,000
New +$3.45M
ENLV icon
2
Enlivex Ltd
ENLV
$32.8M
$1.8M 6.34%
+25,708
New +$2.84M
DMK
3
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$1.21M 4.26%
+48,542
New +$2.06M
BXRX
4
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$1.07M 3.76%
+309
New +$2.92M
IMNN icon
5
Imunon
IMNN
$6.72M
$1.03M 3.62%
+5,822
New +$1.46M
EMWP
6
DELISTED
Eros Media World PLC
EMWP
$794K 2.79%
+24,048
New +$1.32M
PHIO icon
7
Phio Pharmaceuticals
PHIO
$12M
$637K 2.24%
+3,334
New +$2.05M
VSTM icon
8
Verastem
VSTM
$536M
$614K 2.16%
+19,380
New +$486K
PPBT
9
Purple Biotech
PPBT
$1.28M
$605K 2.12%
+989
New +$1.21M
RESN
10
DELISTED
Resonant Inc.
RESN
$600K 2.11%
+405,274
New +$781K
REPL icon
11
Replimune Group
REPL
$455M
$584K 2.05%
58,595
-351,933
-86% -$5.25M
PTE
12
DELISTED
PolarityTE, Inc. Common Stock
PTE
$487K 1.71%
+18,050
New +$978K
NOVN
13
DELISTED
Novan, Inc. Common Stock
NOVN
$435K 1.53%
+291,485
New +$1.66M
SVRA icon
14
Savara
SVRA
$1.14B
$434K 1.52%
204,666
– –
AMRS
15
DELISTED
Amyris Inc.
AMRS
$288K 1.01%
112,639
-1,967,022
-95% -$5.74M
TTPH
16
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$266K 0.93%
+208,074
New +$425K
NTBL
17
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$246K 0.86%
5,197
-13,882
-73% -$654K
FAMI icon
18
Farmmi Inc
FAMI
$5.87M
$229K 0.8%
178
+113
+174% +$190K
BLPH
19
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$210K 0.74%
+19,200
New +$129K
CVM icon
20
PUT
CEL-SCI Corp
CVM
$21.3M
$198K 0.7%
+573
New +$209K
MCF
21
DELISTED
Contango Oil & Gas Co.
MCF
$137K 0.48%
91,120
-608,880
-87% -$1.91M
RGLS
22
DELISTED
Regulus Therapeutics
RGLS
$129K 0.45%
28,015
-10,582
-27% -$92.3K
SLGL icon
23
Sol-Gel Technologies
SLGL
$278M
$71K 0.25%
+1,007
New +$112K
VERBW
24
DELISTED
Verb Technology Company, Inc. Warrant
VERBW
$67K 0.24%
240,000
– –
XCUR icon
25
Exicure
XCUR
$10M
$66K 0.23%
299
-7,796
-96% -$2.47M
1
2

Similar funds

EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
YSP
Yarra Square Partners New York $111M AUM 41.61% 1-Year Est. Return
GIM
Greenwich Investment Management Norwalk, Connecticut $109M AUM 9.72% 1-Year Est. Return
FWM
FMFE Wealth Management Syracuse, New York $108M AUM
CPG
Custom Portfolio Group Englewood, Colorado $127M AUM
WCM
Windham Capital Management Boston, Massachusetts $128M AUM 12.44% 1-Year Est. Return
ETIA
Epic Trust Investment Advisors Richland, Washington $90.8M AUM 22.03% 1-Year Est. Return
RCM
Rain Capital Management Lake Oswego, Oregon $142M AUM 15.53% 1-Year Est. Return

CVI Holdings's Q1 2020 Portfolio in Review

As of Q1 2020, CVI Holdings held 53 positions worth $28.5M, down 60% from $71M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

CVI Holdings withdrew a net $44.1M in Q1 2020, closing 16 positions and reducing 7 holdings. Its most notable exit was Abeona Therapeutics, an estimated $17.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 67% a quarter earlier, followed by Communication Services and Technology.

Against the trend, CVI Holdings opened a new position in Yunhong International Unit worth $3.33M.

  • CVI Holdings's largest Q1 2020 buy was Yunhong International Unit: 350,000 shares worth $3.33M.
  • CVI Holdings added most to Farmmi Inc in Q1 2020, an estimated $190K increase.
  • CVI Holdings's biggest Q1 2020 reduction was Amyris Inc., cutting an estimated $5.74M.
  • CVI Holdings fully exited Abeona Therapeutics in Q1 2020, selling an estimated $17.1M.
  • CVI Holdings's ten largest holdings make up 80% of its $28.5M portfolio in Q1 2020.
  • CVI Holdings opened 16 new positions and closed 16 in Q1 2020.
  • CVI Holdings's portfolio value fell 60% quarter-over-quarter to $28.5M.

Based on CVI Holdings's 13F filing for Q1 2020, filed 15 May 2020.